Pusceddu, C.; De Francesco, D.; Melis, L.; Ballicu, N.; Fancellu, A.
The Role of a Navigational Radiofrequency Ablation Device and Concurrent Vertebral Augmentation for Treatment of Difficult-to-Reach Spinal Metastases. Curr. Oncol. 2021, 28, 4004-4015.
https://doi.org/10.3390/curroncol28050340
AMA Style
Pusceddu C, De Francesco D, Melis L, Ballicu N, Fancellu A.
The Role of a Navigational Radiofrequency Ablation Device and Concurrent Vertebral Augmentation for Treatment of Difficult-to-Reach Spinal Metastases. Current Oncology. 2021; 28(5):4004-4015.
https://doi.org/10.3390/curroncol28050340
Chicago/Turabian Style
Pusceddu, Claudio, Davide De Francesco, Luca Melis, Nicola Ballicu, and Alessandro Fancellu.
2021. "The Role of a Navigational Radiofrequency Ablation Device and Concurrent Vertebral Augmentation for Treatment of Difficult-to-Reach Spinal Metastases" Current Oncology 28, no. 5: 4004-4015.
https://doi.org/10.3390/curroncol28050340
APA Style
Pusceddu, C., De Francesco, D., Melis, L., Ballicu, N., & Fancellu, A.
(2021). The Role of a Navigational Radiofrequency Ablation Device and Concurrent Vertebral Augmentation for Treatment of Difficult-to-Reach Spinal Metastases. Current Oncology, 28(5), 4004-4015.
https://doi.org/10.3390/curroncol28050340